Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.
about
The role of cryptococcal antigen assay in diagnosis and monitoring of cryptococcal meningitisPleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature reviewHost immunity to Cryptococcus neoformansExtensive Central Nervous System Cryptococcal Disease Presenting as Immune Reconstitution Syndrome in a Patient with Advanced HIV: Report of a Case and Review of Management Dilemmas and StrategiesCryptococcus gattii infectionsImplications of climate change (global warming) for the healthcare system.Cryptococcal meningitis in systemic lupus erythematosus patients: pooled analysis and systematic review.Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals.Central nervous system cryptococcosis in solid organ transplant recipients: clinical relevance of abnormal neuroimaging findings.A prospective descriptive study of cryptococcal meningitis in HIV uninfected patients in Vietnam - high prevalence of Cryptococcus neoformans var grubii in the absence of underlying disease.Management of Cryptococcus gattii meningoencephalitis.Follow-up of epidemiological data of cryptococcosis in Austria, Germany and Switzerland with special focus on the characterization of clinical isolates.CNS aspergillosis: recognition, diagnosis and management.Cryptococcus gattii in the United States: genotypic diversity of human and veterinary isolatesDeterminants of disease presentation and outcome during cryptococcosis: the CryptoA/D studyNeuropsychiatric manifestation of confusional psychosis due to Cryptococcus neoformans var. grubii in an apparently immunocompetent host: a case reportCryptococcal meningitis: epidemiology and therapeutic options.Puerperal brain cryptococcoma in an HIV-negative woman successfully treated with fluconazole: a case report.The past, present and future of antimycotic combination therapy.Heteroresistance of Cryptococcus gattii to fluconazole.Phenotypic differences of Cryptococcus molecular types and their implications for virulence in a Drosophila model of infection.Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.Pseudallescheria boydii brain abscess successfully treated with voriconazole and surgical drainage: case report and literature review of central nervous system pseudallescheriasis.Fatal disseminated Cryptococcus gattii infection in New MexicoEpidemiology of Cryptococcus gattii, British Columbia, Canada, 1999-2007.Recent advances in management of cryptococcal meningitis: commentary.Emerging and reemerging neurologic infections.Retrospective study of the epidemiology and clinical manifestations of Cryptococcus gattii infections in Colombia from 1997-2011.Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1.The role of host gender in the pathogenesis of Cryptococcus neoformans infections.Cerebellar cryptococcosis characterized by a space-occupying lesion in an immunocompetent non-HIV patient.Effects of pentoxifylline or dexamethasone in combination with amphotericin B in experimental murine cerebral cryptococcosis: evidence of neuroexcitatory pathogenic mechanisms.Cryptococcus gattii: a resurgent fungal pathogenChronic meningitis: a diagnostic challenge highlighted in a case of cryptococcal meningoencephalitis in an apparently immunocompetent older womanIsolation of Cryptococcus gattii from Oregon soil and tree bark, 2010-2011Cryptococcosis in HIV negative patients: findings on chest radiography.Biochemical comparison of the Cu,Zn superoxide dismutases of Cryptococcus neoformans var. neoformans and Cryptococcus neoformans var. gattiiCryptococcus gattii genotype VGI infection in New England.Treatment principles for Candida and Cryptococcus.Does the Capsule Interfere with Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Cryptococcus neoformans and Cryptococcus gattii?
P2860
Q24538877-E3C551EB-F1C4-4570-A385-547B742E8B64Q26782063-7E13F7B7-E4B9-4D9E-B38D-84D935F0DFECQ26823438-0B6FBFFA-A6A1-4FB6-812F-36C1242410A9Q26852378-95F0907C-63E4-45D1-91FB-14B98252A04AQ27002687-590DBFE2-69DD-4333-ABCA-0F505E9D71C8Q30224617-BE11BD13-7C7A-4C7A-BD16-47C51AE97DB3Q30245599-0890467E-F9A1-4118-8B0B-D69E0702DEBDQ30403990-9F9CBA15-1780-4DD9-8266-43B3804F8354Q30438585-68A392D8-890D-445F-B7D5-EA4BA707AE44Q30495712-444E8CDB-CAEE-4410-8371-6967C5FED07AQ30873978-AFCDAC10-BA0D-4CEE-A223-E6D2730CE495Q30978580-31F5B448-93DD-4D7E-9315-6C5E359D3EF3Q31118905-87D4A46A-793D-4C76-AFE1-3E478B602B33Q31138137-21F020D0-C99A-4780-97C3-00C942BE4836Q33272469-C698F2EE-D6FB-47C2-AB60-575FD4007215Q33580250-728D4432-A0D2-4952-86E4-25317369FDD6Q33633343-A9D46302-3029-4563-9EBF-1C12088160DDQ33707104-C37E69A7-BDCD-4B8F-8E10-759CD43AD29DQ33760507-1C22CB62-9369-4204-AD7A-8B60D780F201Q33876577-33FA87AA-5BC2-4907-94D4-52B9817B6F9FQ33899747-631846CA-F37A-44C6-9C6C-D91DE7EB8C40Q34020746-C8A16239-4E72-4509-AF80-5AA305842C1AQ34052582-BD98A165-FB32-4A77-B37E-AE4B1CB9A532Q34110199-D15A7773-2BA2-46F6-B945-4DA01C06E512Q34216198-1745EEAE-3817-4E7B-9D0C-64FAB7BCB521Q34389849-AD27AE5A-BF14-4C44-BF3F-9F9BD26A4198Q34418533-F4B8A5C5-AEFF-40F5-81CD-A7347CF9E6F2Q34549620-1BC5E35C-2A24-44DB-9C82-CC238B1E9BBDQ34596637-51EE4445-56BD-4BAF-A873-E202B8798466Q34760386-EC67C88C-6439-4C65-AC95-CD04D3B9A0EFQ34775783-F10EC566-E0A3-4793-A728-8C62886DEA33Q35124388-CFB442F8-1062-450E-9109-05395F7DC0F4Q35489889-105B6D82-A32D-4ECA-98C1-43B4BBB59EA8Q35519756-7283EE22-DBF1-4C55-9A55-260F760BEC37Q35531707-78C7EA3F-D62C-4AC0-8C54-F82DA81E2610Q35532573-C296DA8F-00BB-416C-A7AE-F3AB6D1EB164Q35566809-71A13328-4887-4060-B2D0-07AF54F529D4Q35569074-C625727A-0C50-4EB1-8326-44BBB135816AQ35664186-B2EB6F3A-59A4-48E5-9715-3724836425D1Q35867195-9BE31630-313E-4ACC-A9E1-AD549CD1D644
P2860
Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Cryptococcal disease of the CN ...... al manifestations and outcome.
@en
type
label
Cryptococcal disease of the CN ...... al manifestations and outcome.
@en
prefLabel
Cryptococcal disease of the CN ...... al manifestations and outcome.
@en
P2093
P356
P1476
Cryptococcal disease of the CN ...... al manifestations and outcome.
@en
P2093
Allworth AM
Gottlieb T
McGregor AR
Mitchell DH
Papanaoum K
Richards MJ
P304
P356
10.1093/CLINIDS/20.3.611
P407
P577
1995-03-01T00:00:00Z